The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders.
View / Open Files
Authors
Mason, Luke
Wooldridge, Caroline
Auyeung, Bonnie
Brogna, Claudia
Ambrosino, Sara
Baumeister, Sarah
Brammer, Michael
Brandeis, Daniel
Bölte, Sven
Bourgeron, Thomas
Bours, Carsten
de Bruijn, Yvette
Chakrabarti, Bhismadev
Cornelissen, Ineke
Acqua, Flavio Dell'
Durston, Sarah
Ecker, Christine
Faulkner, Jessica
Frouin, Vincent
Garces, Pilar
Goyard, David
Ham, Lindsay M
Holt, Rosemary
Kundu, Prantik
D'ardhuy, Xavier Liogier
Lombardo, Michael V
Mandl, René
Meyer-Lindenberg, Andreas
Mueller, Nico
O'Dwyer, Laurence
Oldehinkel, Marianne
Oranje, Bob
Pandina, Gahan
Persico, Antonio M
Sabet, Jessica
Sacco, Roberto
Cáceres, Antonia San José
Tost, Heike
Waldman, Jack
Zwiers, Marcel P
Spooren, Will
Buitelaar, Jan K
Publication Date
2017-01Journal Title
Molecular autism
ISSN
2040-2392
Volume
8
Pages
24
Language
English
Type
Article
This Version
VoR
Physical Medium
Electronic-eCollection
Metadata
Show full item recordCitation
Loth, E., Charman, T., Mason, L., Tillmann, J., Jones, E. J., Wooldridge, C., Ahmad, J., et al. (2017). The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders.. Molecular autism, 8 24. https://doi.org/10.1186/s13229-017-0146-8
Keywords
Brain, Saliva, Hair, Humans, Magnetic Resonance Imaging, Longitudinal Studies, Individuality, Siblings, Phenotype, Genetic Heterogeneity, Patient Selection, Adult, Child, Female, Male, Eye Movement Measurements, Neuroimaging, Biomarkers, Autism Spectrum Disorder, Precision Medicine
Sponsorship
European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA) FP7 Innovative Medicines Initiative (IMI) (115300)
Identifiers
External DOI: https://doi.org/10.1186/s13229-017-0146-8
This record's URL: https://www.repository.cam.ac.uk/handle/1810/266613
Rights
Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International